Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Oct;8(10):1015-8.
doi: 10.3201/eid0810.020444.

Public health in the time of bioterrorism

Bradley A Perkins  1 , Tanja Popovic, Kevin Yeskey
Affiliations

Public health in the time of bioterrorism

Bradley A Perkins et al. Emerg Infect Dis. 2002 Oct.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Bradley A. Perkins, Guest Editor. Dr. Perkins is chief, Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention (CDC), which has technical responsibility for the epidemiologic and laboratory aspects of Bacillus anthracis, and selected other bacterial agents of public health importance. Dr. Perkins led the CDC field team in the investigation of the index case of inhalational anthrax in Florida and participated broadly in the 2001 anthrax investigation and response. His research interests include vaccine evaluation, bacterial meningitis, bioterrorism, and emerging infectious diseases. He has worked extensively on the control and prevention of meningococcal disease in the United States, Africa, and around the globe
Figure 2
Figure 2
Tanja Popovic, Guest Editor. Dr. Popovic is chief, Epidemiologic Investigations Laboratory, Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention. As the subject matter expert on laboratory aspects of B. anthracis and anthrax at CDC, she and her staff trained laboratory scientists in all 50 states to isolate and identify B. anthracis using standard methodologies in the fall of 2000, and have performed thousands of tests for isolation of B. anthracis, its confirmatory identification and molecular subtyping during the 2001 anthrax investigation. In addition to bioterrorism preparedness and response, her research focuses on laboratory diagnosis and molecular epidemiology of bacterial meningitis and diphtheria.
Figure 3
Figure 3
Kevin Yeskey, Guest Editor. Dr. Yeskey is director, Bioterrorism Preparedness and Response Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). He has served as deputy director of Emergency Public Health in the Division of Emergency and Environmental Health Services, National Center for Environmental Health, CDC. His previous assignments include associate professor and vice chair, Department of Military and Emergency Medicine, Uniformed Services University School of Medicine, and chief medical officer, United States Public Health Service Office of Emergency Preparedness. Dr. Yeskey’s experience with disaster response includes work on hurricanes, earthquakes, floods, mass migrations, and terrorist bombings.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Traeger MS, Wiersma S, Rosenstein NE, Malecki JM, Shepard CW, Raghunathan P, et al. First case of bioterrorism-related inhalational anthrax in the United States□Palm Beach County, Florida 2001. Emerg Infect Dis. 2002;8:1029–34. - PMC - PubMed
    1. Maillard J-M, Cline S, Turner L, Fischer M. First case of bioterrorism-related inhalational anthrax, Florida, 2001: North Carolina investigation. Emerg Infect Dis. 2002;8:1035–8. - PMC - PubMed
    1. Centers for Disease Control and Prevention. Biological and chemical terrorism: strategic plan for preparedness and response. MMWR Morb Mortal Wkly Rep. 2000;49:1–26. - PubMed
    1. Khan AS, Morse S, Lillibridge S. Public-health preparedness for biologic terrorism in the USA. Lancet. 2000;356:1179–82. 10.1016/S0140-6736(00)02769-0 - DOI - PubMed
    1. Hoffmaster AR, Meyer RF, Bowen M, Marston CK, Weyant RS, Barnett GA, et al. Evaluation and validation of a real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis. Emerg Infect Dis. 2002;8:1178–82. - PMC - PubMed

MeSH terms

LinkOut - more resources